Literature DB >> 4375309

Use of BCG as an immunostimulant in the surgical treatment of carcinoma of the lung.

F R Edwards, F Whitwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4375309      PMCID： PMC470219          DOI： 10.1136/thx.29.6.654

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  11 in total

1.  Results of the surgical treatment of bronchogenic carcinoma.

Authors:  D M SENSENIG; N P ROSSI; J L EHRENHAFT
Journal:  Surg Gynecol Obstet       Date:  1963-03

2.  The incomputable factor in cancer prognosis.

Authors:  G GORDON-TAYLOR
Journal:  Br Med J       Date:  1959-02-21

3.  Effect of Bacillus Calmette-Guerin infection on transplanted tumours in the mouse.

Authors:  L J OLD; D A CLARKE; B BENACERRAF
Journal:  Nature       Date:  1959-07-25       Impact factor: 49.962

4.  Sinus histiocytosis of lymph nodes in cancer.

Authors:  M M BLACK; F D SPEER
Journal:  Surg Gynecol Obstet       Date:  1958-02

5.  The role of the reticuloendothelial system in the host reaction to neoplasia.

Authors:  L J OLD; B BENACERRAF; D A CLARKE; E A CARSWELL; E STOCKERT
Journal:  Cancer Res       Date:  1961-10       Impact factor: 12.701

6.  Effect of BCG and allogeneic tumor cells on adenovirus type 12 tumorigenesis in mice.

Authors:  H O Sjögren; J Ankerst
Journal:  Nature       Date:  1969-03-01       Impact factor: 49.962

7.  Effect of postoperative empyema on survival of patients with bronchogenic carcinoma.

Authors:  H Takita
Journal:  J Thorac Cardiovasc Surg       Date:  1970-05       Impact factor: 5.209

8.  Immunity to cancer.

Authors:  R Wyburn-Mason
Journal:  Br Med J       Date:  1969-06-21

9.  Evidence of immunological reactions to autochthonous cancer in man.

Authors:  C M Southam
Journal:  Eur J Cancer       Date:  1965-11       Impact factor: 9.162

10.  The histopathology of lung cancer in Liverpool: a survey of bronchial biopsy histology.

Authors:  F WHITWELL
Journal:  Br J Cancer       Date:  1961-09       Impact factor: 7.640
View more
  8 in total

1.  Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.

Authors:  M A Schwarz; J U Gutterman; E M Hersh; S P Richman; G M Mavligit
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

2.  Anticoagulants in the treatment of small cell carcinoma of the bronchus.

Authors:  C F Stanford
Journal:  Thorax       Date:  1979-02       Impact factor: 9.139

3.  Oral administration of BCG as an adjuvant to surgical treatment of carcinoma of the bronchus.

Authors:  A B Miller; H E Taylor; M A Baker; D J Dodds; R Falk; A Frappier; D P Hill; A Jindani; S Landi; A S Macdonald; J W Thomas; C Wall
Journal:  Can Med Assoc J       Date:  1979-07-07       Impact factor: 8.262

Review 4.  Immunology of bronchial carcinoma.

Authors:  D A Evans
Journal:  Thorax       Date:  1976-10       Impact factor: 9.139

5.  Use of BCG as an immunostimulant in the surgical treatment of carcinoma of lung: a five-year follow-up report.

Authors:  F R Edwards; F Whitwell
Journal:  Thorax       Date:  1978-04       Impact factor: 9.139

6.  Use of BCG as an immunostimulant after resection of carcinoma of the lung: a two-year assessment of a trial of 500 patients.

Authors:  F R Edwards
Journal:  Thorax       Date:  1979-12       Impact factor: 9.139

Review 7.  Safety and clinical usage of newcastle disease virus in cancer therapy.

Authors:  Han Yuen Lam; Swee Keong Yeap; Mehdi R Pirozyan; Abdul Rahman Omar; Khatijah Yusoff; Abd Aziz Suraini; Noorjahan Banu Alitheen
Journal:  J Biomed Biotechnol       Date:  2011-10-26

8.  BCG treatment of malignant pleural effusions in the rat.

Authors:  M V Pimm; D G Hopper; R W Baldwin
Journal:  Br J Cancer       Date:  1976-10       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.